You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys HIV Duo IVD Elecsys® HIV Duo CPS_000848 07229542190 HIV duo Elecsys E2G 300 Elecsys HIV Duo 07613336119297 Reagents, kits 300 tests cobas e 402/801 true 08836973190 HIV duo Elecsys E2G 300 V2 Elecsys HIV Duo 07613336166949 Reagents, kits 300 tests cobas e 402/801 true 08836973192 HIV Duo Elecsys E2G 10x300 Elecsys HIV Duo 07613336224175 Reagents, kits 10 x 300 tests cobas e 402/801 true 07229542500 Elecsys HIV Duo en 4 FF000000046CB60E FF00000001C3820E 07229542190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08836973500 Elecsys HIV Duo en 3 FF0000000526F00E FF00000003F94B0E 08836973190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08836973500 Elecsys HIV Duo en 2 FF0000000446970E FF0000000446970E 08836973190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08836973500 Elecsys HIV Duo en 1 FF00000003F94B0E FF00000003F94A0E 08836973190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08836973503 Elecsys HIV Duo en 1 FF000000061DFF0E FF000000061DFF0E 08836973192 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en